| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |